Our results support the idea that AR-expressing luminal stem-like cells could function as cancer-initiating and relapse-initiating cells in castration-resistant prostate tumors, suggesting that novel strategies targeting this cell population should be considered in the treatment of prostate cancer. Here, AR is linked to prostate cancer.